Companies: 10,795·Total market cap: $144.5T
Kadmon Holdings, Inc.

Kadmon Holdings, Inc.

KDMNNYSEHealthcare
$9.50
+$0.00(+0.00%)
Market Cap$0
P/E Ratio
52W High$9.495
52W Low$9.48

Kadmon Holdings, Inc. (KDMN) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

KDMN · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
166.2M +25.65% YoY Change
FY · as of Dec 31, 2020 · Reported in USD
vs 132.3M in FY 2019
Diluted Shares Outstanding
166.2M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+25.65%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+42.5%
2017 → 2020
5-Year CAGRincreasing
+36.3%
2015 → 2020
10-Year CAGR

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2020Latest
Diluted Shares: 166.2M
166.2M
+25.65%
FY 2019
Diluted Shares: 132.3M
132.3M
+35.55%
FY 2018
Diluted Shares: 97.6M
97.6M
+70.03%
FY 2017
Diluted Shares: 57.4M
57.4M
+142.48%
FY 2016
Diluted Shares: 23.7M
23.7M
-33.02%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs KDMN
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+971.0%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+832.4%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+447.4%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+440.2%
#7
Kadmon Holdings, Inc.KDMN
Kadmon Holdings, Inc.YOU
166.2M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Kadmon Holdings, Inc. (KDMN) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2020, Kadmon Holdings, Inc. reports 166.2M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Kadmon Holdings, Inc.'s basic shares outstanding (166.2M) represents currently issued shares. Diluted shares outstanding (166.2M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Kadmon Holdings, Inc.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Kadmon Holdings, Inc. (KDMN) shares outstanding history from 2014 to 2020. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Kadmon Holdings, Inc. shares outstanding for the fiscal year ending December 31, 2020 were 166.2M, a 25.65% increase year-over-year. Kadmon Holdings, Inc. FY 2020 shares outstanding were 166.2M, a +25.65% increase from FY 2019.

Kadmon Holdings, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

KDMN shares outstanding · 4 questions

As of December 31, 2020, Kadmon Holdings, Inc. (KDMN) has approximately 166.2M basic shares outstanding and 166.2M diluted shares outstanding. This represents a +25.65% year-over-year increase from FY 2019 (132.3M). The increase may reflect equity compensation issuances or secondary offerings.

KDMN shares outstandinghow many shares does KDMN haveKDMN basic shares 2020KDMN diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Kadmon Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09